Embryonic SCS from bone marrow express pluripotent markers such as oct-4, nanog, rex-1, ssea-3, ssea-4, tra-1-80/70/60/50/40% and tra-1-81, and exhibit increased telomerase activity, which will insectes are the preferred candidate for therapeutic use.33 For the treatment of neurodegenerative diseases, methods of <a href=https://www.gestimenergia.it/hello-world/>https://www.gestimenergia.it/hello-world/</a> (NSCs) from different parts of gray matter of the fetus have been well studied|researched|analyzed.
|